These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
839 related articles for article (PubMed ID: 22848170)
1. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Wahajuddin ; Arora S Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170 [TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351 [TBL] [Abstract][Full Text] [Related]
3. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent. Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545 [TBL] [Abstract][Full Text] [Related]
4. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs). Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting. Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920 [TBL] [Abstract][Full Text] [Related]
6. Magnetic nanoparticle-based drug delivery for cancer therapy. Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592 [TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells. Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004 [TBL] [Abstract][Full Text] [Related]
8. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Zhi D; Yang T; Yang J; Fu S; Zhang S Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124 [TBL] [Abstract][Full Text] [Related]
9. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Hong SC; Lee JH; Lee J; Kim HY; Park JY; Cho J; Lee J; Han DW Int J Nanomedicine; 2011; 6():3219-31. PubMed ID: 22238510 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery. Unterweger H; Tietze R; Janko C; Zaloga J; Lyer S; Dürr S; Taccardi N; Goudouri OM; Hoppe A; Eberbeck D; Schubert DW; Boccaccini AR; Alexiou C Int J Nanomedicine; 2014; 9():3659-76. PubMed ID: 25120363 [TBL] [Abstract][Full Text] [Related]
11. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery. Mohammed L; Ragab D; Gomaa H Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596 [TBL] [Abstract][Full Text] [Related]